ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

15 Health Benefits of Chia Seeds, According to Science

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

Magnesium Deficiency Raises Your Risk of Many Chronic Ailments

CoQ10's Potential Capabilities for Your Health

Testosterone replacement therapy associated with improved urinary, sexual function

How Can Melatonin Benefit You?

Cloves: Boost Your Immune System the Sweet and Spicy Way

The Many Potential Health Benefits of Curcumin

8 Chia Seed Recipes

Cinnamon Health Benefits Proven

 
Print Page
Email Article

Estrogen Therapy in Postmenopausal Women with Alzheimer's May Worsen Memory

  [ 206 votes ]   [ Discuss This Article ]
www.ProHealth.com • November 8, 2002


Postmenopausal women with Alzheimer's disease who undergo long-term estrogen replacement therapy (ERT) may make their memory loss worse, according to a new study from researchers at the University of Arizona.

The study in the October issue of Behavioral Neuroscience, a journal published by the American Psychological Association (APA), used female rats to study the effect of ERT on memory. The findings are transferable to humans because the conditions reproduced in the study are similar to that of postmenopausal women undergoing ERT and who have existing brain inflammation caused by a neurodegenerative illness like Alzheimer's.

G. L. Wenk, Ph.D., and colleagues at the Arizona Research Laboratories at the University of Arizona had 40 rats perform a water maze task to look at the interaction of two conditions known to exist within the brains of female Alzheimer's patients, 1) the presence of chronic neuroinflammation, and 2) having too much or not enough estrogen. Both of these conditions are likely to precede the onset of symptoms associated with Alzheimer's.

As part of the experiment, some of the rats had their ovaries surgically removed to mimic the changes seen in postmenopausal women. The researchers found that the removal of the rats' ovaries was not enough to impair performance in the water maze task. However, the introduction of either sustained estrogen replacement therapy or chronic brain inflammation did impair memory performance in the rats. Furthermore, the combined occurrence of both conditions (sustained estrogen replacement therapy and longer term brain inflammation) significantly worsened cognitive performance beyond that produced by either condition alone.

"A therapy designed to mimic the natural cycle of hormone fluctuation may provide a more effective therapy to slow the progression of Alzheimer's disease in postmenopausal women," according to the researchers. They add that their findings were confirmed by a 2000 study in the Journal of the American Medical Association (JAMA) involving a long term, placebo-controlled study that examined the effects of estrogen replacement therapy on cognitive function in a large group of women with mild to moderate Alzheimer's. The effects of ERT were initially beneficial, but the performance of women receiving sustained ERT declined more than that of women receiving the placebo treatment.

"When considered together, the results of this and other clinical trials suggest a pattern of beneficial effects on cognitive function after relatively short-term ERT; however, this beneficial effect is attenuated, and possibly reversed, after much longer treatment regimens," report the authors. "Although a comparison between humans and rodents must be made with caution, it is interesting that continuous long-term estrogen therapy immediately after [ovary removal] in the present study parallels the detrimental cognitive effect seen in postmenopausal Alzheimer's disease women who receive continuous, long-term ERT decades after the onset of menopause."



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Energy NADH™ 12.5mg Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?
Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map